SCHEMBL5322367

SCHEMBL5322367

CC(=O)c1ccc(Sc2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.68
LMNA P02545 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
ALDH1A1 P00352 1/20 0.59
USP7 Q93009 1/20 0.46
TSHR P16473 1/20 0.46
MAPT P10636 2/20 0.41
SRD5A2 P31213 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ATM Q13315 1/20 0.40
EIF4E P06730 1/20 0.40
GRM5 P41594 1/20 0.40
HAO1 Q9UJM8 1/20 0.39
RHEB Q15382 1/20 0.39
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364210 0.84 TSHR (0.62) HPGDLMNAL3MBTL1ALDH1A1TSHR
SCHEMBL835108 0.82 HPGD (1.00) HPGDLMNAL3MBTL1ALDH1A1MAPT
SCHEMBL1755726 0.82 HPGD (1.00) HPGDLMNAL3MBTL1ALDH1A1MAPT
SCHEMBL5322959 0.81 HPGD (0.79) HPGDLMNAL3MBTL1ALDH1A1USP7
SCHEMBL313211 0.78 TSHR (0.64) HPGDTSHRMAPTSRD5A2MEN1
SCHEMBL8478583 0.78 TSHR (0.64) HPGDTSHRMAPTSRD5A2MEN1
SCHEMBL29655535 0.78 TSHR (0.64) HPGDTSHRMAPTSRD5A2MEN1
SCHEMBL10957865 0.78 HAO1 (0.53) LMNATSHRMAPTMEN1KMT2A
SCHEMBL678860 0.77 SCN9A (0.68) HPGDALDH1A1MEN1KMT2A
SCHEMBL30837205 0.76 SCN9A (0.58) TSHRMAPTSRD5A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007114916-A2 ARYLBENZYLPIPERIDINE COMPOUNDS H. LUNDBECK A/S (DK) 2007-10-11 WO disclosed
US-20070082934-A1 Substituted 4-aryloxy and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of cell proliferation UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2007-04-12 US disclosed
WO-2005044263-A1 SUBSTITUTED 4-ARYLOXY AND 4-ARYLSULFANYL-PHENYL-2-AMINOTHIAZOLES AS INHIBITORS OF CELL PROLIFERATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2005-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082934-A1 Substituted 4-aryloxy and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of cell proliferation MKI67, CCNI, CDK4 HPGD 2433/4885LMNA 4630/4885L3MBTL1 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.